中国实用儿科杂志 ›› 2022, Vol. 37 ›› Issue (8): 595-600.DOI: 10.19538/j.ek2022080607

• “一切为了人民健康———我们这十年”专栏·专题笔谈 • 上一篇    下一篇

儿童骨质疏松症的诊治

  

  1. 深圳市儿童医院内分泌科,广东  深圳  518038
  • 出版日期:2022-08-06 发布日期:2022-08-31
  • 通讯作者: 苏喆,电子信箱:su_zhe@126.com
  • 基金资助:
    广东省卫生健康委员会高水平临床重点专科(深圳市配套建设经费)项目(SZGSP012);深圳市科技计划资助 深圳市科技创新委员会可持续发展项目(KCXFZ20201221173400002);深圳市科技计划资助深圳市科技创新委员基础研究课题(JCYJ20210324123610028)

Diagnosis and treatment of osteoporosis in children

  1. Department of Endocrin-ology,Shenzhen Children's Hospital,Shenzhen  518038,China
  • Online:2022-08-06 Published:2022-08-31

摘要: 各种原发或继发病因所致儿童骨质疏松症日益受到关注。因仍处于生长阶段,儿童骨质疏松症的诊断、治疗、随访策略无法完全参照成人标准。早期识别、正确诊断各种类型的骨质疏松症,合理治疗并做好药物不良反应监测,加强长期健康管理,对改善患儿生活质量及远期骨骼健康意义重大。在儿童骨质疏松症的检测方式、药物治疗等领域尚存在较大的探索空间。

关键词: 骨质疏松症, 儿童, 双膦酸盐

Abstract: More and more attention has been paid to osteoporosis in children caused by primary or secondary causes. Because children are still in the growth stage, the diagnosis,treatment and follow-up strategies of osteoporosis in children cannot completely follow the adult standards. Early identification and correct diagnosis of different types of osteoporosis in children,proper treatment and monitoring of adverse drug reaction and continuous health management are of great significance to improving patients' quality of life and long-term bone health. There is still a lot to explore in the detection methods and drug therapy of osteoporosis in children.

Key words: osteoporosis, child, bisphosphonates